Daxor Corp. PT receives Investment Bank Analyst Rating Update
Gainers: Boxlight Corporation (NASDAQ:BOXL) +47%. Microbot Medical (NASDAQ:MBOT) +33%. Regional Health Properties (NYSEMKT:RHE) +33%. Blink Charging (NASDAQ:BLNK) +27%. iFresh...
Gainers: Pyxis Tankers (NASDAQ:PXS) +41%. Beazer Homes USA (NYSE:BZH) +33%. Servotronics (NYSEMKT:SVT) +21%. Cocrystal Pharma (NASDAQ:COCP) +20%. Solid Biosciences...
Daxor Corporation is a medical instrumentation and biotechnology company. The Company is focused on blood volume measurement. The Company has developed and marketed the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the food and drug administration (FDA) to provide objective quantification of blood volume status and composition compared to patient-specific norms. Over 60,000+ tests have been performed at hospital centers across the United States, enhancing hospital performance metrics in a broad range of surgical and medical conditions, including reducing mortality and readmissions in heart failure and critical care. It has ongoing multicenter trials in the areas of COVID-19 and heart failure treatment with support from the National Institutes of Health (NIH) and is under contract developing analyzers.